Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 10/20 | 0.47 |
| ▸ | JAK2 | O60674 | 3/20 | 0.39 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 4/20 | 0.37 |
| ▸ | CCNC | P24863 | 1/20 | 0.37 |
| ▸ | CDK8 | P49336 | 1/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.36 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30490300 | 0.89 | TYK2 (0.48) | TYK2JAK2LRRK2JAK1CCNC | |
| SCHEMBL29686783 | 0.85 | TYK2 (0.47) | TYK2JAK2JAK1IRAK4 | |
| SCHEMBL24498517 | 0.85 | TYK2 (0.47) | TYK2JAK2JAK1IRAK4 | |
| SCHEMBL30490252 | 0.83 | JAK2 (0.55) | TYK2JAK2JAK1 | |
| SCHEMBL30724634 | 0.83 | TYK2 (0.49) | TYK2JAK2JAK1 | |
| SCHEMBL29685327 | 0.81 | JAK2 (0.62) | TYK2JAK2JAK1 | |
| SCHEMBL24498190 | 0.81 | JAK2 (0.62) | TYK2JAK2JAK1 | |
| SCHEMBL30490071 | 0.81 | TYK2 (0.51) | TYK2JAK2JAK1 | |
| SCHEMBL30490068 | 0.80 | TYK2 (0.46) | TYK2JAK2JAK1 | |
| SCHEMBL30490080 | 0.80 | TYK2 (0.49) | TYK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116283954-A | Hydroxamate compound, preparation method and application thereof | 深圳微芯生物科技股份有限公司 | 2023-06-23 | — | — | CN | disclosed |